[
  {
    "ts": null,
    "headline": "Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?",
    "summary": "LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.",
    "url": "https://finnhub.io/api/news?id=f68a23763a8cc6c1054870a6bb24f1e66abc3d1c622ead267d08ccc751476d51",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752759900,
      "headline": "Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?",
      "id": 135993033,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.",
      "url": "https://finnhub.io/api/news?id=f68a23763a8cc6c1054870a6bb24f1e66abc3d1c622ead267d08ccc751476d51"
    }
  },
  {
    "ts": null,
    "headline": "3 Stocks Including Grab Holdings That May Be Undervalued For Your Portfolio",
    "summary": "Over the last 7 days, the United States market has remained flat, yet it has experienced a notable 12% rise over the past year with earnings forecasted to grow by 15% annually. In such an environment, identifying undervalued stocks can offer potential opportunities for investors seeking to enhance their portfolios by focusing on companies that may be trading below their intrinsic value.",
    "url": "https://finnhub.io/api/news?id=7bb93a9241c8ad81712113ab1172c1cf54fc6e06abf3c04322c0ec797ad94a8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752752273,
      "headline": "3 Stocks Including Grab Holdings That May Be Undervalued For Your Portfolio",
      "id": 135993034,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Over the last 7 days, the United States market has remained flat, yet it has experienced a notable 12% rise over the past year with earnings forecasted to grow by 15% annually. In such an environment, identifying undervalued stocks can offer potential opportunities for investors seeking to enhance their portfolios by focusing on companies that may be trading below their intrinsic value.",
      "url": "https://finnhub.io/api/news?id=7bb93a9241c8ad81712113ab1172c1cf54fc6e06abf3c04322c0ec797ad94a8c"
    }
  },
  {
    "ts": null,
    "headline": "This Pick Withstood the GLP-1 Challenge. Stick With the Stock.",
    "summary": "One year ago, we recommended buying  ResMed  stock after concerns that weight loss drugs would hurt demand for its sleep apnea treatments knocked shares down.  The market was concerned a new  Eli Lilly  pill would reduce patients’ obstructive sleep apnea, or OSA, enough to lower demand for ResMed’s CPAP machines and masks.  From that point—even as Lilly started selling its OSA treatment—ResMed’s earnings grew aggressively.",
    "url": "https://finnhub.io/api/news?id=f34de7c293b28fbb2adaae0364a37e9a5729bac4aeb879e72bb2188e6d87b529",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752728400,
      "headline": "This Pick Withstood the GLP-1 Challenge. Stick With the Stock.",
      "id": 135993035,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "One year ago, we recommended buying  ResMed  stock after concerns that weight loss drugs would hurt demand for its sleep apnea treatments knocked shares down.  The market was concerned a new  Eli Lilly  pill would reduce patients’ obstructive sleep apnea, or OSA, enough to lower demand for ResMed’s CPAP machines and masks.  From that point—even as Lilly started selling its OSA treatment—ResMed’s earnings grew aggressively.",
      "url": "https://finnhub.io/api/news?id=f34de7c293b28fbb2adaae0364a37e9a5729bac4aeb879e72bb2188e6d87b529"
    }
  }
]